Editorial |

Smallpox Immunization in the 21st Century:  The Old and the New

Mary E. Wright, MD MPH; Anthony S. Fauci, MD
JAMA. 2003;289(24):3306-3308. doi:10.1001/jama.289.24.3306.
Text Size: A A A
Published online


Just over 6 months ago a decision was made to reinstitute smallpox vaccination for selected segments of the US population.1 This decision to implement a pre-event smallpox vaccination program was based on the concern that smallpox could be used as an agent of bioterrorism; however, certain questions about the risk of smallpox vaccination in a 21st-century setting arose.2,3 Among these was the possibility that the current United States population might be more vulnerable to serious adverse effects of the smallpox vaccine due to a relative increase—compared with 3 to 4 decades ago—in conditions affecting the immune system such as the use of immunosuppressive drugs and the presence of human immunodeficiency virus infection in the community. A consequence of this change in population profile could be an increased incidence of established adverse events as well as the emergence of heretofore unrecognized adverse events. At the same time that these issues were being raised, there was also an appreciation that the immunization of a new generation of individuals provided an opportunity to apply 21st-century technology to the study of vaccinia-induced immunity.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 4

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles